459 related articles for article (PubMed ID: 23652165)
61. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
62. Influenza vaccination and Guillain Barre syndrome.
Geier MR; Geier DA; Zahalsky AC
Clin Immunol; 2003 May; 107(2):116-21. PubMed ID: 12763480
[TBL] [Abstract][Full Text] [Related]
63. Vaccines and the risk of Guillain-Barré syndrome.
Chen Y; Zhang J; Chu X; Xu Y; Ma F
Eur J Epidemiol; 2020 Apr; 35(4):363-370. PubMed ID: 31858323
[TBL] [Abstract][Full Text] [Related]
64. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
Kawai AT; Li L; Kulldorff M; Vellozzi C; Weintraub E; Baxter R; Belongia EA; Daley MF; Jacobsen SJ; Naleway A; Nordin JD; Lee GM
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):548-53. PubMed ID: 24497128
[TBL] [Abstract][Full Text] [Related]
65. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan.
Yen CC; Wei KC; Wang WH; Huang YT; Chang YC
JAMA Netw Open; 2022 Sep; 5(9):e2232571. PubMed ID: 36129709
[TBL] [Abstract][Full Text] [Related]
66. Guillain-Barré syndrome surveillance during National Influenza Vaccination Campaign, New York, U.S.A., 2009.
Giambrone GP; Zansky SM; Eidson M; Duncan PG; McNutt LA; Birkhead GS
Emerg Infect Dis; 2013 Dec; 19(12):1956-62. PubMed ID: 24274387
[TBL] [Abstract][Full Text] [Related]
67. Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barré Syndrome after influenza vaccination during the 2010/11 influenza season.
Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Chillarige Y; Wernecke M; Kelman J; Ball R
Vaccine; 2020 Feb; 38(9):2221-2228. PubMed ID: 31932134
[TBL] [Abstract][Full Text] [Related]
68. Guillain-Barré syndrome after H1N1 influenza: a concern.
Wiwanitkit V
Neuroepidemiology; 2013; 40(4):295. PubMed ID: 23485791
[No Abstract] [Full Text] [Related]
69. Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.
Huang WT; Yang HW; Liao TL; Wu WJ; Yang SE; Chih YC; Chuang JH
PLoS One; 2013; 8(3):e58827. PubMed ID: 23536827
[TBL] [Abstract][Full Text] [Related]
70. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
[TBL] [Abstract][Full Text] [Related]
71. Guillain-Barré syndrome and the 1978-1979 influenza vaccine.
Hurwitz ES; Schonberger LB; Nelson DB; Holman RC
N Engl J Med; 1981 Jun; 304(26):1557-61. PubMed ID: 7231501
[TBL] [Abstract][Full Text] [Related]
72. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
[TBL] [Abstract][Full Text] [Related]
73. Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination?
Li S; Zhu J
Vaccine; 2012 Aug; 30(38):5585. PubMed ID: 22728223
[No Abstract] [Full Text] [Related]
74. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.
Souayah N; Yacoub HA; Khan HM; Farhad K; Maybodi L; Qureshi AI; Menkes DL
J Clin Neurosci; 2012 Aug; 19(8):1089-92. PubMed ID: 22705140
[TBL] [Abstract][Full Text] [Related]
75. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
McNeil MM; Arana J; Stewart B; Hartshorn M; Hrncir D; Wang H; Lamias M; Locke M; Stamper J; Tokars JI; Engler RJ
Vaccine; 2012 Mar; 30(14):2421-6. PubMed ID: 22310205
[TBL] [Abstract][Full Text] [Related]
76. [Evidence of indications of influenza vaccine and its efficacy--including Guillain-Barré syndrome as an adverse reaction(?)].
Watanabe A
Nihon Rinsho; 2003 Nov; 61(11):1987-91. PubMed ID: 14619443
[TBL] [Abstract][Full Text] [Related]
77. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.
Cortese A; Baldanti F; Tavazzi E; Carnevale L; Minoli L; Lozza A; Marchioni E
J Neurol Sci; 2012 Jan; 312(1-2):173-6. PubMed ID: 22000408
[TBL] [Abstract][Full Text] [Related]
78. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
[TBL] [Abstract][Full Text] [Related]
79. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
[TBL] [Abstract][Full Text] [Related]
80. Guillain-Barré syndrome following influenza vaccination: A 15-year nationwide population-based case-control study.
Levison LS; Thomsen RW; Andersen H
Eur J Neurol; 2022 Nov; 29(11):3389-3394. PubMed ID: 35913431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
